Genomic Analysis of Clostridium perfringens BEC/CPILE-Positive, Toxinotype D and E Strains Isolated from Healthy Children
Raymond Kiu, Kathleen Sim, Alex Shaw and 4 more
Toxins · 2019
doi:10.3390/toxins11090543 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
<i>Clostridium perfringens</i> toxinotype D, toxinotype E, and gastroenteritis-linked BEC/CPILE-positive strains have never been reported in healthy children. We isolated, whole-genome sequenced and bioinformatically characterised three <i>C. perfringens</i> isolates—type D (IQ1), type E (IQ2) and BEC/CPILE-positive (IQ3), recovered from the stools of three healthy two-year-olds, which were further compared to 128 <i>C. perfringens</i> genomes available from NCBI. The analysis uncovered a previously under-described putative toxin gene <i>alv</i> (alveolysin) encoded by isolates IQ2 and IQ3, which appeared to be a clade-specific trait associated with strains from domestic animals. A plasmid analysis indicated that the iota-toxin was encoded on a near-intact previously described plasmid pCPPB-1 in type E strain IQ2. The BEC genes <i>becA</i> and <i>becB</i> were carried on a near-identical pCPOS-1 plasmid previously associated with Japanese gastroenteritis outbreaks. Furthermore, a close phylogenetic relatedness was inferred between the French <i>C. perfringens</i> type E isolates cp515.17 and newly sequenced IQ2, suggesting geographical links. This study describes novel <i>C. perfringens</i> isolates from healthy individuals which encode important toxin genes, indicating the potential spread of these veterinary and clinically important strains and mobile genetic elements, and highlights areas for future research.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.